X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (169) 169
humans (155) 155
high-dose antithrombin (69) 69
hematology (63) 63
disseminated intravascular coagulation (54) 54
female (46) 46
male (46) 46
peripheral vascular disease (45) 45
high-dose aprotinin (41) 41
animals (38) 38
severe sepsis (38) 38
surgery (38) 38
sepsis (35) 35
cardiopulmonary bypass (34) 34
middle aged (31) 31
septic shock (31) 31
cardiac & cardiovascular systems (30) 30
double-blind (30) 30
antithrombin (29) 29
abridged index medicus (28) 28
coagulation (28) 28
aged (26) 26
treatment outcome (25) 25
risk factors (23) 23
critically-ill patients (22) 22
pharmacology & pharmacy (22) 22
anticoagulants - therapeutic use (21) 21
oncology (21) 21
concomitant heparin (20) 20
anticoagulants (19) 19
antithrombins - therapeutic use (19) 19
disseminated intravascular coagulation - drug therapy (19) 19
mortality (19) 19
sepsis - drug therapy (19) 19
transplantation (19) 19
critical care medicine (18) 18
heparin (18) 18
activated protein-c (17) 17
fibrinolysis (17) 17
high-dose chemotherapy (17) 17
inflammation (17) 17
blood-loss (16) 16
care and treatment (16) 16
aprotinin - therapeutic use (15) 15
blood loss, surgical - prevention & control (15) 15
high-dose methylprednisolone (15) 15
open-heart-surgery (15) 15
research (15) 15
thrombosis (15) 15
anesthesiology (14) 14
medicine & public health (14) 14
randomized controlled-trial (14) 14
respiratory system (14) 14
sepsis - complications (14) 14
hematology, oncology and palliative medicine (13) 13
prospective studies (13) 13
recombinant proteins - therapeutic use (13) 13
safety (13) 13
adult (12) 12
efficacy (12) 12
medicine, general & internal (12) 12
antineoplastic agents - adverse effects (11) 11
antithrombin iii - therapeutic use (11) 11
bone-marrow-transplantation (11) 11
cancer (11) 11
cardiac-surgery (11) 11
chemotherapy (11) 11
child (11) 11
diagnostic-criteria (11) 11
health aspects (11) 11
hemostatics - therapeutic use (11) 11
retrospective studies (11) 11
stem-cell transplantation (11) 11
anticoagulants - adverse effects (10) 10
aprotinin (10) 10
cardiopulmonary bypass - adverse effects (10) 10
hemostasis (10) 10
human soluble thrombomodulin (10) 10
molecular-weight heparin (10) 10
therapy (10) 10
tumor-necrosis-factor (10) 10
acute lymphoblastic-leukemia (9) 9
analysis (9) 9
blood coagulation (9) 9
blood coagulation - drug effects (9) 9
clinical neurology (9) 9
diagnosis (9) 9
drug therapy (9) 9
placebo-controlled trial (9) 9
randomized controlled trials as topic (9) 9
stem cells (9) 9
thrombomodulin (9) 9
tranexamic acid (9) 9
activation (8) 8
anti-inflammatory agents - therapeutic use (8) 8
aprotinin - adverse effects (8) 8
blood (8) 8
blood coagulation tests (8) 8
complications and side effects (8) 8
disseminated intravascular coagulation - etiology (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


SHOCK, ISSN 1073-2322, 12/2016, Volume 46, Issue 6, pp. 623 - 631
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 09/2014, Volume 12, Issue 9, pp. 1470 - 1479
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 03/2018, Volume 16, Issue 3, pp. 455 - 457
Recently, two meta-analyses examined the effect of antithrombin on mortality in patients with sepsis and disseminated intravascular coagulation (DIC) with... 
antithrombin | risk of bias | cochrane | meta‐analysis | disseminated intravascular coagulation | sepsis | CONTROLLED-TRIALS | meta-analysis | CONCOMITANT HEPARIN | PERIPHERAL VASCULAR DISEASE | HIGH-DOSE ANTITHROMBIN | HEMATOLOGY | Disseminated intravascular coagulation | Usage | Mortality | Sepsis | Antithrombin | Index Medicus
Journal Article
Critical Care, ISSN 1364-8535, 12/2013, Volume 17, Issue 6, pp. R297 - R297
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 06/2016, Volume 6, Issue 1, pp. 27544 - 27544
Antithrombin is a key inhibitor of the coagulation cascade, but it may also function as an anti-inflammatory, anti-angiogenic, anti-viral and anti-apoptotic... 
CELL LUNG-CANCER | LATENT ANTITHROMBIN | METASTASIS | MULTIDISCIPLINARY SCIENCES | MOLECULAR-WEIGHT HEPARIN | ENDOTHELIAL-CELLS | CONCOMITANT HEPARIN | HIGH-DOSE ANTITHROMBIN | EXTRACELLULAR-MATRIX | SEVERE SEPSIS | SERPIN ANTITHROMBIN | Index Medicus
Journal Article
Internal Medicine, ISSN 0918-2918, 2019, Volume 58, Issue 7, pp. 907 - 914
Journal Article
Clinical and Applied Thrombosis/Hemostasis, ISSN 1076-0296, 12/2018, Volume 24, Issue 9_suppl, pp. 145S - 149S
For success in clinical trials, eliminating inclusion of patients with irreversible recovery is important. The purpose of this study was to identify the... 
clinical trial | antithrombin | mortality | disseminated intravascular coagulation | sequential organ failure assessment score | sepsis | MULTICENTER | EFFICACY | HIGH-DOSE ANTITHROMBIN | PROTEIN-C | THROMBOMODULIN | IMMUNOTHROMBOSIS | BENEFIT PROFILE | ANTICOAGULANT-THERAPY | PERIPHERAL VASCULAR DISEASE | CONCENTRATE USE | HEMATOLOGY | Original
Journal Article
Journal Article